EVOLV Trademark

Trademark Overview

On Wednesday, February 24, 2016, a trademark application was filed for EVOLV with the United States Patent and Trademark Office. The USPTO has given the EVOLV trademark a serial number of 86918844. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, September 19, 2023. This trademark is owned by Omron Healthcare, Inc.. The EVOLV trademark is filed in the Medical Instrument Products category with the following description:

Blood pressure monitors

General Information

Serial Number86918844
Word MarkEVOLV
Filing DateWednesday, February 24, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, September 19, 2023
Registration Number5168033
Registration DateTuesday, March 21, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2016

Trademark Statements

Pseudo MarkEVOLVE
Goods and ServicesBlood pressure monitors

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, February 29, 2016
Primary Code010
First Use Anywhere DateTuesday, January 31, 2017
First Use In Commerce DateTuesday, January 31, 2017

Trademark Owner History

Party NameOmron Healthcare, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHoffman Estates, IL 60169
US
Party NameOmron Healthcare, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLake Forest, IL 60045
US
Party NameOmron Healthcare, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLake Forest, IL 60045
US

Trademark Events

Event DateEvent Description
Saturday, February 27, 2016NEW APPLICATION ENTERED
Monday, February 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 1, 2016NOTICE OF PSEUDO MARK E-MAILED
Thursday, May 5, 2016ASSIGNED TO EXAMINER
Tuesday, May 10, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 25, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 14, 2016PUBLISHED FOR OPPOSITION
Tuesday, June 14, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 31, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, January 31, 2017SOU TEAS EXTENSION RECEIVED
Friday, February 3, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 31, 2017SOU EXTENSION 1 FILED
Monday, February 6, 2017SOU EXTENSION 1 GRANTED
Tuesday, January 31, 2017USE AMENDMENT FILED
Monday, February 6, 2017STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 14, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 15, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 21, 2017REGISTERED-PRINCIPAL REGISTER
Monday, March 21, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, March 17, 2023TEAS SECTION 8 & 15 RECEIVED
Tuesday, September 19, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 19, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, September 19, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, March 21, 2026COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

evolv monitors pressure blood